Avapritinib versus Placebo in Indolent Systemic Mastocytosis
Jason Gotlib(Stanford University), Robyn M. Scherber(Blueprint Medicines (United States)), Johanna Ungerstedt(Karolinska University Hospital), Paul Van Daele(Erasmus MC), Prithviraj Bose(The University of Texas MD Anderson Cancer Center), Matthew P. Giannetti(Brigham and Women's Hospital), Tracy I. George(University of Utah), Jens Panse(University Hospital Cologne), Cecilia Arana Yi(Mayo Clinic Hospital), Brenton G. Mar(Otsuka (Japan)), Mattias Mattsson(Uppsala University Hospital), Deepti Radia(Guy's and St Thomas' NHS Foundation Trust), Mark Heaney(Immunovaccine (Canada)), Mar Guilarte(Vall d'Hebron Institut de Recerca), Thanai Pongdee(Mayo Clinic), Sonia Cerquozzi(University of Calgary), Friederike Wortmann(Universitäres Kinderwunschzentrum Lübeck), Pankit Vachhani(University of Alabama at Birmingham), Caroline Gaudy‐Marqueste(Aix-Marseille Université), Vito Sabato(University of Antwerp), Princess U. Ogbogu(National Institute of Allergy and Infectious Diseases), Andrew Kuykendall(Moffitt Cancer Center), Massimo Triggiani, Ilda Bidollari(Blueprint Medicines (United States)), Frank Siebenhaar(Humboldt-Universität zu Berlin), Lawrence B. Schwartz(Memorial Sloan Kettering Cancer Center), Iván Álvarez‐Twöse(Hospital Virgen del Valle), Philippe Schafhausen(University Medical Center Hamburg-Eppendorf), Sigurd Broesby‐Olsen(Odense University Hospital), Mariana Castells(Brigham and Women's Hospital), Brant R. Ward(Virginia Commonwealth University), Tsewang Tashi(University of Utah), Ingunn Dybedal(Karolinska University Hospital), Celalettin Üstün(NHS Blood and Transplant), Stéphane Barète(Sorbonne Université), Karin Hartmann(University of Basel), Hanneke Oude Elberink(University Medical Center Groningen), Minakshi Taparia(University of Alberta), William Shomali(Stanford Medicine), Daniel J. DeAngelo(Dana-Farber Cancer Institute), Huimin Lin(Takeda (United States)), Erin Sulllivan(Blueprint Medicines (United States)), Patrizia Bonadonna(Azienda Ospedaliera Universitaria Integrata Verona), Andreas Reiter(Heidelberg University), Peter Vadas(St. Michael's Hospital), Lindsay Rein(Duke University), Nauman M. Butt(Clatterbridge Cancer Centre NHS Foundation Trust), C. Bulaï Livideanu(Université Fédérale de Toulouse Midi-Pyrénées), Mark Rafferty(Beatson West of Scotland Cancer Centre), Stephen T. Oh(Washington University in St. Louis)
Cited by 74
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.7k
Diagnostic criteria and classification of mastocytosis: a consensus proposal
|Leukemia Research|2001|1.1k
Cetuximab Shows Activity in Colorectal Cancer Patients With Tumors That Do Not Express the Epidermal Growth Factor Receptor by Immunohistochemistry
|Journal of Clinical Oncology|2005|1.1k
Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia
|Science Translational Medicine|2016|916